Search Results - "Sachdeo, S. K."

Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients by Sachdeo, R. C., Sachdeo, S. K., Levy, R. H., Streeter, A. J., Bishop, F. E., Kunze, K. L., Mather, G. G., Roskos, L. K., Shen, D. D., Thummel, K. E., Trager, W. F., Curtin, C. R., Doose, Dennis R., Gisclon, L. G., Bialer, Meir

“…Purpose: To evaluate the potential pharmacokinetic interactions between topiramate (TPM) and phenytoin (PHT) in patients with epilepsy by studying their…”
Get full text

Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy by Sachdeo, R C, Sachdeo, S K, Walker, S A, Kramer, L D, Nayak, R K, Doose, D R

“…We studied the steady-state pharmacokinetic profile of topiramate (TPM) as a function of dose and the effects of comedication with carbamazepine (CBZ). We…”
Get more information

Tolerability and Pharmacokinetics of Monotherapy Felbamate Doses of 1,200–6,000 mg/day in Subjects with Epilepsy by Sachdeo, Rajesh, Narang‐Sachdeo, Satinder K., Shumaker, R. C., Perhach, J. L., Lyness, W. H., Rosenberg, A.

“…Summary : Purpose: Felbamate (FBM) pharmacokinetic parameters, safety and tolerability in the dose range of 1,200–6,000 mg/day were assessed in two open‐label…”
Get full text

Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients by Sachdeo, Rajesh C., Sachdeo, S.K., Levy, R.H., Streeter, A.J., Bishop, F.E., Kunze, K.L., Mather, G.G., Roskos, L.K., Shen, D.D., Thummel, K.E., Trager, W.F., Curtin, C. R., Doose, Dennis R., Gisclon, L.G., Bialer, Meir

Get full text